# Source BioScience

> Source BioScience is a VC fund in Nottingham backing Medical and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Nottingham, United Kingdom
- Total investments: 1
- Last investment: Oct 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/source-bioscience
- X (Twitter): https://twitter.com/SourceBio
- Website: https://sourcebiointernational.com/
- Facebook: https://www.facebook.com/sbslifesciences/

Source BioScience is a VC fund in Nottingham focused on Medical and Therapeutics. Source Bioscience provides laboratory services and products to the healthcare and clinical, life science research and biopharma industries. Services include diagnostic testing for cancer and other infectious disease, DNA sequencing and contract research activities, cryostorage and stability testing. Products include serology products for blood andtissue banking, life science research reagents and controlled environment chambers.

## Contacts

5 contacts available for Source BioScience. Shizune tracks 5 team members at Source BioScience. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/source-bioscience?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Therapeutics | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Emma Turner | Chief Information Officer | 0 | — |
| Jay LeCoque | CEO | 0 | — |
| Marc Thomas | Integration Director Digital Pathology | 0 | — |
| Tom Burr | Chief Scientific Officer | 0 | — |
| Tony Ratcliffe | Chief Financial Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Procyon Diagnostics | Procyon Diagnostics is a provider of new precision assays for early cancer detection. |  | Pre-Seed | Oct 22, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [Queen Mary University of London](https://shizune.co/investors/profile/queen-mary-university-of-london) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does Source BioScience invest in?

Source BioScience invests primarily in Medical, Therapeutics and Health Diagnostics startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Source BioScience?

Public channels for Source BioScience include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Source BioScience?

The team at Source BioScience includes Emma Turner (Chief Information Officer), Jay LeCoque (CEO) and Marc Thomas (Integration Director Digital Pathology). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co